Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2003
Business Overview: The Company operates outpatient physical and occupational therapy clinics providing pre- and post-operative care, sports injury treatment, and rehabilitation. As of December 31, 2003, the Company operated 242 clinics in 35 states, with concentrations in Texas, Michigan, Wisconsin, Florida, Virginia, Oklahoma, Maine, and New Jersey. The average age of clinics was 3.96 years. The Company primarily generates revenue through third-party payors, including commercial insurers, managed care, workers' compensation, and Medicare.
Key Financial Metrics
| Metric ($ in thousands) | 2003 | 2002 | 2001 |
|---|---|---|---|
| Net Revenues | $105,568 | $94,739 | $80,948 |
| Net Income | $7,331 | $8,488 | $7,071 |
| Diluted EPS | $0.61 | $0.67 | $0.55 |
| Operating Income | $16,997 | $18,874 | $16,948 |
| Cash and Cash Equivalents | $16,822 | $7,610 | $8,121 |
| Total Assets | $52,473 | $41,033 | $36,742 |
| Long-Term Debt | $83 | $2,350 | $3,021 |
| Current Ratio | 6.09 | 7.93 | 5.92 |
Operational Metrics: Total patient visits increased to 1,111,852 in 2003 (up 11% from 2002). However, average daily visits per clinic declined to 19.9 in 2003 from 22.1 in 2002. Net patient revenue per visit increased to $92.84.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 11% to $105.6 million, driven by an 11% increase in patient visits and a slight increase in revenue per visit. New clinics opened in 2002 and 2003 contributed significantly to this growth.
- Profitability Decline: Net income decreased 14% to $7.3 million. This was primarily due to increased operating costs, specifically a 17% rise in salaries and related costs and a 24% increase in corporate office costs.
- Cost Pressures: Clinic operating costs as a percentage of net revenues rose to 71% in 2003 from 68% in 2002. Salaries and related costs increased to 50% of net revenues from 47%.
- Bad Debt Improvement: The provision for doubtful accounts decreased 44% to $932,000, reflecting improved collection efforts. The allowance for bad debts as a percentage of receivables dropped to 20% from 25%.
- Liquidity: Cash and cash equivalents increased by $9.2 million to $16.8 million, supported by $17.5 million in cash provided by operating activities.
Guidance, Outlook, Risks, and Unusual Items
Guidance and Outlook
The Company plans to open between 45 and 50 new clinics in 2004, contingent on identifying suitable locations and qualified therapists. Management expects new clinics to incur initial operating losses before becoming profitable. The Company anticipates that clinics opened in 2003 will begin favorably impacting results in 2004.
Risks and Contingencies
- Reimbursement Rates: Approximately 79% of revenue comes from commercial insurers and managed care, and 20% from Medicare. Cost-containment initiatives by payors could reduce reimbursement rates and margins.
- Medicare Limits: A moratorium was placed on the Medicare therapy cap ($1,590 limit) for 2003, 2004, and 2005. If the moratorium is not extended after 2005, revenue could be adversely impacted.
- Declining Visits: Average daily visits per clinic have declined from 22.9 in 2001 to 19.9 in 2003. Management attributes this to higher patient co-payments, deductibles, unemployment, and competition.
- Convertible Debt: The Company has $1.7 million in Series C Convertible Subordinated Notes due June 30, 2004. If the stock price is below $3.33 at maturity, the Company may be required to repay the debt in cash rather than converting it to equity.
- Regulatory Compliance: The business is subject to extensive federal and state regulations, including the Stark Law and Fraud and Abuse Law. Non-compliance could result in penalties or exclusion from government programs.
Investor Verification Checklist
- Visit Trends: Verify the sustainability of the decline in average daily visits per clinic (19.9 in 2003) and its impact on mature clinic profitability.
- Debt Conversion: Monitor the stock price relative to the $3.33 conversion price of the Series C Notes due in June 2004 to assess potential cash outflow requirements.
- Medicare Policy: Track legislative developments regarding the extension of the Medicare therapy cap moratorium beyond 2005.
- Cost Structure: Analyze the trend of rising salary and corporate costs as a percentage of revenue to determine if margin compression is structural.
- Expansion Execution: Assess the Company's ability to recruit qualified therapists to meet the goal of opening 45-50 new clinics in 2004.